Rathi recommends booking profit in Lupin at current valuations. He has a neutral rating and a ‘hold‘ on the Sun Pharma stock because there are several triggers which can drive the earning surprise positively
first published: Jul 23, 2013 02:52 pm
A collection of the most-viewed Moneycontrol videos.

Iran Fires Missiles Across Middle East As Ships Hit In Gulf | Hormuz Crisis Deepens

PM Modi Speech: 5 Big Highlights You Can’t Miss | Congress Targeted, Gulf Nations Praised

ON CAM: Iran ‘BURNS’ Two Israeli Hermes Drones; IRGC Mocks IDF | Watch

Why The U.S.-Israel War With Iran Is Driving Oil Prices Higher | Explained
You are already a Moneycontrol Pro user.


